Literature DB >> 2137553

Phosphorylation of the ETS-2 protein: regulation by the T-cell antigen receptor-CD3 complex.

S Fujiwara1, S Koizumi, R J Fisher, N K Bhat, T S Papas.   

Abstract

Phosphorylation of the human ets-2 protein in response to mitogenic signals to T lymphocytes was investigated in Jurkat cells. Activation of the cells by antibodies against the T-cell antigen receptor-CD3 complex or by concanavalin A was followed within 5 min by increased phosphorylation of the protein, as shown by a mobility shift of the protein from 54 to 56 kilodaltons in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and increased incorporation of 32P. The Ca2+ ionophores A23187 and ionomycin were able to mimic this effect, suggesting that this phosphorylation is mediated by Ca2+.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137553      PMCID: PMC361013          DOI: 10.1128/mcb.10.3.1249-1253.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  25 in total

1.  The action of oncogenes in the cytoplasm and nucleus.

Authors:  R A Weinberg
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

2.  The erg gene: a human gene related to the ets oncogene.

Authors:  E S Reddy; V N Rao; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

Review 3.  The role of the T3/antigen receptor complex in T-cell activation.

Authors:  A Weiss; J Imboden; K Hardy; B Manger; C Terhorst; J Stobo
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

4.  A putative second cell-derived oncogene of the avian leukaemia retrovirus E26.

Authors:  D Leprince; A Gegonne; J Coll; C de Taisne; A Schneeberger; C Lagrou; D Stehelin
Journal:  Nature       Date:  1983 Nov 24-30       Impact factor: 49.962

5.  Temporal and tissue-specific expression of mouse ets genes.

Authors:  N K Bhat; R J Fisher; S Fujiwara; R Ascione; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Molecular cloning of the ets proto-oncogene of the sea urchin and analysis of its developmental expression.

Authors:  Z Q Chen; N C Kan; L Pribyl; J A Lautenberger; E Moudrianakis; T S Papas
Journal:  Dev Biol       Date:  1988-02       Impact factor: 3.582

7.  erg, a human ets-related gene on chromosome 21: alternative splicing, polyadenylation, and translation.

Authors:  V N Rao; T S Papas; E S Reddy
Journal:  Science       Date:  1987-08-07       Impact factor: 47.728

8.  The Drosophila ets-2 gene: molecular structure, chromosomal localization, and developmental expression.

Authors:  L J Pribyl; D K Watson; M J McWilliams; R Ascione; T S Papas
Journal:  Dev Biol       Date:  1988-05       Impact factor: 3.582

9.  The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active.

Authors:  D K Watson; M J McWilliams-Smith; M F Nunn; P H Duesberg; S J O'Brien; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester.

Authors:  A Truneh; F Albert; P Golstein; A M Schmitt-Verhulst
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

View more
  16 in total

1.  cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.

Authors:  C B Thompson; C Y Wang; I C Ho; P R Bohjanen; B Petryniak; C H June; S Miesfeldt; L Zhang; G J Nabel; B Karpinski
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

2.  PEA1 and PEA3 enhancer elements are primary components of the polyomavirus late transcription initiator element.

Authors:  W Yoo; M E Martin; W R Folk
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Sequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I.

Authors:  S D Gitlin; R Bosselut; A Gégonne; J Ghysdael; J N Brady
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.

Authors:  N K Bhat; C B Thompson; T Lindsten; C H June; S Fujiwara; S Koizumi; R J Fisher; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins.

Authors:  S John; R B Reeves; J X Lin; R Child; J M Leiden; C B Thompson; W J Leonard
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

6.  ets-1 in astrocytes: expression and transmitter-evoked phosphorylation.

Authors:  L F Fleischman; L Holtzclaw; J T Russell; G Mavrothalassitis; R J Fisher
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

7.  GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction.

Authors:  A Avots; A Hoffmeyer; E Flory; A Cimanis; U R Rapp; E Serfling
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

8.  Role for Ets-2(Thr-72) transcription factor in stage-specific thymocyte development and survival.

Authors:  Ian B Fisher; Mike Ostrowski; Natarajan Muthusamy
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

9.  Expression of a 91-kilodalton PEA3-binding protein is down-regulated during differentiation of F9 embryonal carcinoma cells.

Authors:  M E Martin; X Y Yang; W R Folk
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

10.  A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells.

Authors:  J M Leiden; C Y Wang; B Petryniak; D M Markovitz; G J Nabel; C B Thompson
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.